Two prominent advocates of “integrative medicine” bemoan the “practice drift” they see in their specialty, in which doctors drift farther and farther away from their training. What this means is (although it would never be admitted) is that these “integrative medicine” doctors are drifting further and further into quackery. Too bad this is a feature, not a bug.
Search: “"John Weeks"”
We found 28 results for your search.
Helene Langevin has been named the new director of the National Center for Complemenary and Integrative Health. Given her history of dodgy acupuncture research, my prediction is that the quackery will flow again at NCCIH, the way it did in the 1990s when Tom Harkin zealously protected it from any attempt to impose scientific rigor on it.
The Oregon Health Authority is on the verge of passing a radical policy that would require chronic pain patients receiving Medicaid to have their opioids tapered to zero while covering “nonpharmacologic treatments for pain” that include primarily acupuncture, chiropractic, massage therapy, and other “alternative” treatments. Not surprisingly, the Oregon Chronic Pain Task Force, which is responsible for this proposed infliction of quackery on the most vulnerable, has three acupuncturists and a chiropractor sitting on it.
In 2014, the Society for Integrative Oncology first published clinical guidelines for the care of breast cancer patients. Not surprisingly, SIO advocated “integrating” dubious therapies with oncology. Last week, the most influential oncology society, the American Society of Clinical Oncology (ASCO), endorsed a 2017 update to the SIO guidelines, thus endorsing the “integration” of quackery with oncology and paving the way for insurance coverage. The advance of quackademic medicine in oncology continues apace.
Proponents of integrating quackery like most traditional Chinese medicine (TCM) into real medicine portray themselves as underdogs being persecuted by big pharma and the FDA. In China, however, the case of Tan Qindong shows that in China TCM is big pharma.
